FAVONI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.585
EU - Europa 950
AS - Asia 398
AF - Africa 68
SA - Sud America 4
OC - Oceania 1
Totale 3.006
Nazione #
US - Stati Uniti d'America 1.579
GB - Regno Unito 240
IT - Italia 188
DE - Germania 154
SE - Svezia 154
CN - Cina 100
SG - Singapore 95
IN - India 74
VN - Vietnam 55
IE - Irlanda 52
JO - Giordania 39
RU - Federazione Russa 33
FR - Francia 30
BG - Bulgaria 27
NG - Nigeria 25
ZA - Sudafrica 22
UA - Ucraina 18
PK - Pakistan 16
EE - Estonia 13
AT - Austria 12
TG - Togo 10
CI - Costa d'Avorio 9
FI - Finlandia 8
CA - Canada 6
BE - Belgio 4
NL - Olanda 4
CH - Svizzera 3
IL - Israele 3
UZ - Uzbekistan 3
BR - Brasile 2
CZ - Repubblica Ceca 2
GR - Grecia 2
HK - Hong Kong 2
IR - Iran 2
JP - Giappone 2
KR - Corea 2
LB - Libano 2
QA - Qatar 2
RO - Romania 2
SC - Seychelles 2
AR - Argentina 1
AU - Australia 1
BY - Bielorussia 1
CL - Cile 1
HR - Croazia 1
LT - Lituania 1
PL - Polonia 1
TH - Thailandia 1
Totale 3.006
Città #
Southend 227
Fairfield 213
Woodbridge 122
Ashburn 115
Chandler 112
Houston 103
Seattle 92
Ann Arbor 91
Singapore 85
Princeton 80
Wilmington 80
Cambridge 78
Dublin 52
Amman 39
Turin 39
Santa Clara 28
Sofia 27
Abeokuta 25
Redmond 25
Bologna 23
Westminster 23
Dong Ket 22
San Diego 21
Berlin 20
Chengdu 14
Des Moines 14
Monzuno 14
Nanjing 14
Lomé 10
Saint Petersburg 10
Abidjan 9
Hebei 9
Nanchang 9
Padova 9
Shenyang 9
New York 8
Dearborn 7
Jacksonville 7
Jiaxing 7
Milan 7
Muzaffargarh 7
Redwood City 7
Beijing 6
Hyderabad 6
Olalla 6
Vienna 6
Changsha 5
Helsinki 5
Imola 5
Los Angeles 5
Brussels 4
Chicago 4
Costa Mesa 4
Florence 4
Gujranwala 4
Jinan 4
Pianoro 4
Amsterdam 3
Bühl 3
Lappeenranta 3
Mülheim 3
Norwalk 3
Parma 3
Phoenix 3
San Mateo 3
Seriate 3
Silvi 3
Tianjin 3
Washington 3
Atlanta 2
Bremen 2
Brno 2
Council Bluffs 2
Doha 2
Edmonton 2
Falls Church 2
Frankfurt Am Main 2
Haikou 2
Hangzhou 2
Hefei 2
Hong Kong 2
Lanzhou 2
Lucerne 2
Mahé 2
Monterotondo 2
Mountain View 2
Muenster 2
Napanee 2
Novo Hamburgo 2
Pasco 2
Perugia 2
San Venanzo 2
Taiyuan 2
Tel Aviv 2
Zhengzhou 2
Ardabil 1
Athens 1
Bahawalpur 1
Baotou 1
Bedfordview 1
Totale 2.078
Nome #
Treatment of withdrawal headache in patients with medication overuse headache: a pilot study 127
Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache. 125
Idiopathic intracranial hypertension without papilledema (IIHWOP) in chronic refractory headache 123
A real-world study on unmet medical needs in triptan-treated migraine: Prevalence, preventive therapies and triptan use modification from a large Italian population along two years 112
Interobserver reliability of ICSD-3 diagnostic criteria for disorders of arousal in adults 112
Migraine and sleep disorders. 111
Greater Occipital Nerve Infiltration During Pregnancy in Cluster Headache: A Case Report 106
Vessel-wall MRI in primary headaches: The role of neurogenic inflammation 100
Clinical and radiological prognostic factors in spontaneous intracranial hypotension: a case series 97
Transverse Sinus Stenosis in Refractory Chronic Headache Patients: An Observational Study 95
Superficial siderosis associated with peripheral autonomic failure and tetraventricular hydrocephalus: a case report 93
SPARTACUS: underdiagnosis of chronic daily headache in primary care. 92
The incidental finding of elevated anti GQ1B antibodies in a patient with selective small fiber neuropathy 92
Migraine and cardiovascular diseases. 90
SUNCT/SUNA and neurovascular compression: New cases and critical literature review. 89
Rotigotine Objectively Improves Sleep in Parkinson's Disease: An Open-Label Pilot Study with Actigraphic Recording 88
CGRP and migraine from a cardiovascular point of view: What do we expect from blocking CGRP? 87
Recurrent Reversible Cognitive Impairment in a Cluster Headache Patient: A Case Report 83
Nociception and autonomic nervous system. 82
Quality indicators in headache care: an implementation study in six Italian specialist-care centres 80
null 80
Rare primary headaches in Italian tertiary Headache Centres: Three year nationwide retrospective data from the RegistRare Network 79
Energy Metabolism Impairment in Migraine 78
State and trait anger and its expression in cluster headache compared with migraine: a cross-sectional study 77
Erenumab efficacy in highly resistant chronic migraine: a real-life study 70
Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache 63
Erenumab in 159 high frequency and chronic migraine patients: real-life results from the Bologna Headache Center 62
Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache 60
Nummular headache: a gender-oriented perspective on a case series from the RegistRare Network 59
Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study 58
Vessel-wall MRI in thunderclap headache: A useful tool to answer the riddle? 52
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study) 51
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study 48
P063. Colloid cysts of the third ventricle: a case report 46
Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study) 43
Insights into real-world treatment of cluster headache through a large Italian database: prevalence, prescription patterns, and costs 42
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study 34
Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic 33
Migraine chronification as an allostatic disorder: a proof-of-concept study 18
Is physiotherapy in migraines known to sufferers? A cross-sectional study 14
Self-administered subcutaneous diclofenac sodium in acute migraine attack: A randomized, double-blind, placebo-controlled dose-finding pilot study 14
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study 11
Blood pressure monitoring in elderly migraineurs starting an anti-CGRP monoclonal antibody: a real-world prospective study 7
Greater occipital nerve blockade in cluster headache: effectiveness and safety of a combined injection protocol 5
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study 4
Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study 3
Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance 3
Chronic migraine evolution after 3 months from erenumab suspension: real-world-evidence-life data 3
The ultimate guide to the anti-CGRP monoclonal antibodies galaxy 2
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study 2
An unusual case of anti-basal ganglia encephalitis showing polyradiculoneuritis features 2
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study 2
Moving closer to the ideal migraine acute treatment 2
Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men 2
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience 2
Central and Peripheral Nervous Disorders 2
Totale 3.117
Categoria #
all - tutte 9.487
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.487


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020691 0 15 6 33 76 78 95 116 136 46 47 43
2020/2021399 91 27 4 17 18 11 14 29 60 25 18 85
2021/2022635 37 16 41 31 63 20 13 85 21 75 142 91
2022/2023681 64 69 23 81 67 43 38 38 144 29 65 20
2023/2024290 10 42 23 47 11 51 24 19 8 29 9 17
2024/2025210 50 160 0 0 0 0 0 0 0 0 0 0
Totale 3.117